智通财经APP获悉，心玮医疗-B(06609)再涨超13%，绩后累计涨幅已超40%，截至发稿，涨8.24%，报59.1港元，成交额1343.67万港元。
消息面上，心玮医疗近日发布年度业绩，公司全年实现收入4.08亿元，同比增长46.9%；与此同时，公司当期毛利率稳定在70%以上，净利润达到8334万元，同比实现大幅扭亏为盈，标志着公司在神经介入领域的布局步入收获期。值得注意的是，公司计划于2026年提交A股科创板上市申请。
公司管理层在业绩会上提出多项发展目标：未来三年保持不低于35%的年化收入增长，2028年力争实现国产神经介入品牌市场占有率第一；海外收入方面，预计2028年贡献度达10%以上，规模超1亿元人民币；利润端则致力于实现约20%的净利润率水平，毛利率预计稳定在68%-70%区间，将通过精细化费用管理和规模效应确保盈利稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.